20,642
Views
210
CrossRef citations to date
0
Altmetric
Review Article

pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms

, , , &
Pages 569-581 | Received 22 Nov 2016, Accepted 03 Jan 2017, Published online: 14 Feb 2017

References

  • Ahmad N, Amin MC, Mahali SM, et al. (2014). Biocompatible and mucoadhesive bacterial cellulose-g-poly(acrylic acid) hydrogels for oral protein delivery. Mol Pharm 11:4130–42
  • Ahmad N, Mohd Amin MC, Ismail I, Buang F. (2016). Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles. Expert Opin Drug Deliv 13:621–32
  • Akande J, Yeboah KG, Addo RT, et al. (2010). Targeted delivery of antigens to the gut-associated lymphoid tissues: 2. ex vivo evaluation of lectin-labelled albumin microspheres for targeted delivery of antigens to the M-cells of the Peyer’s patches. J Microencapsul 27:325–36
  • Aleksovski A, Dreu R, Gasperlin M, Planinsek O. (2015). Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups. Expert Opin Drug Deliv 12:65–84
  • Anirudhan TS, Mohan AM. (2014). Novel pH switchable gelatin based hydrogel for the controlled delivery of the anti cancer drug 5-fluorouracil. Rsc Advances 4:12109–18
  • Arbit E. (2004). The physiological rationale for oral insulin administration. Diabetes Technol Ther 6:510–7
  • Basak P, Adhikari B. (2009). Poly (vinyl alcohol) hydrogels for pH dependent colon targeted drug delivery. J Mater Sci Mater Med 20 Suppl 1:S137–46
  • Bell CL, Peppas NA. (1996). Swelling/syneresis phenomena in gel-forming interpolymer complexes. J Biomater Sci Polym Ed 7:671–83
  • Benes L, Claustrat B, Horriere F, et al. (1997). Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: a crossover study with melatonin. J Pharm Sci 86:1115–9
  • Betancourt T, Pardo J, Soo K, Peppas NA. (2010). Characterization of pH-responsive hydrogels of poly(itaconic acid-g-ethylene glycol) prepared by UV-initiated free radical polymerization as biomaterials for oral delivery of bioactive agents. J Biomed Mater Res A 93:175–88
  • Carr DA, Gomez-Burgaz M, Boudes MC, Peppas NA. (2010). Complexation hydrogels for the oral delivery of growth hormone and salmon calcitonin. Ind Eng Chem Res 49:11991–5
  • Chang CH, Lin YH, Yeh CL, et al. (2010). Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of helicobacter pylori. Biomacromolecules 11:133–42
  • Chang Kang H, Bae YH. (2011). Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamide. Biomaterials 32:4914–24
  • Chen L, Tian Z, Du Y. (2004a). Synthesis and pH sensitivity of carboxymethyl chitosan-based polyampholyte hydrogels for protein carrier matrices. Biomaterials 25:3725–32
  • Chen MC, Mi FL, Liao ZX, et al. (2013). Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. Adv Drug Deliv Rev 65:865–79
  • Chen S, Guo F, Deng T, et al. (2016). Eudragit S100-coated chitosan nanoparticles co-loading tat for enhanced oral colon absorption of insulin. AAPS PharmSciTech. [Epub ahead of print]. doi: 10.1208/s12249-016-0594-z
  • Chen SC, Wu YC, Mi FL, et al. (2004b). A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Release 96:285–300
  • Cheng Z, Al Zaki A, Hui JZ, et al. (2012). Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338:903–10
  • Choonara BF, Choonara YE, Kumar P, et al. (2014). A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. Biotechnol Adv 32:1269–82
  • Chuang EY, Lin KJ, Su FY, et al. (2013). Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats. J Control Release 172:513–22
  • Colombo P, Sonvico F, Colombo G, Bettini R. (2009). Novel platforms for oral drug delivery. Pharm Res 26:601–11
  • Cui F, Qian F, Zhao Z, et al. (2009). Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Biomacromolecules 10:1253–8
  • Cui FD, Tao AJ, Cun DM, et al. (2007). Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. J Pharm Sci 96:421–7
  • Dai J, Nagai T, Wang X, et al. (2004). pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Int J Pharm 280:229–40
  • Dai WB, Guo YL, Zhang H, et al. (2015). Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A. Int J Pharm 478:718–25
  • Das S, Subuddhi U. (2015). pH-Responsive guar gum hydrogels for controlled delivery of dexamethasone to the intestine. Int J Biol Macromol 79:856–63
  • De Jaeghere F, Allemann E, Cerny R, et al. (2001). pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs. AAPS PharmSci 3:E8
  • De Jaeghere F, Allemann E, Kubel F, et al. (2000). Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state. J Control Release 68:291–8
  • de Moura MR, Aouada FA, Mattoso LH. (2008). Preparation of chitosan nanoparticles using methacrylic acid. J Colloid Interface Sci 321:477–83
  • De Portu S, Mantovani LG, Ravaioli A, et al. (2010). Cost analysis of capecitabine vs 5-fluorouracil-based treatment for metastatic colorectal cancer patients. J Chemother 22:125–8
  • Deng L, Dong H, Dong A, Zhang J. (2015). A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity. Eur J Pharm Biopharm 97:107–17
  • Dew MJ, Hughes PJ, Lee MG, et al. (1982). An oral preparation to release drugs in the human colon. Br J Clin Pharmacol 14:405–8
  • Ding J, He R, Zhou G, et al. (2012). Multilayered mucoadhesive hydrogel films based on thiolated hyaluronic acid and polyvinylalcohol for insulin delivery. Acta Biomater 8:3643–51
  • Douroumis D. (2011). Orally disintegrating dosage forms and taste-masking technologies; 2010. Expert Opin Drug Deliv 8:665–75
  • Duran-Lobato M, Carrillo-Conde B, Khairandish Y, Peppas NA. (2014). Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation. Biomacromolecules 15:2725–34
  • Edelman ER, Nathan A, Katada M, et al. (2000). Perivascular graft heparin delivery using biodegradable polymer wraps. Biomaterials 21:2279–86
  • El-Shabouri MH. (2002). Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int J Pharm 249:101–8
  • Evans DF, Pye G, Bramley R, et al. (1988). Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29:1035–41
  • Fan B, Xing Y, Zheng Y, et al. (2016). pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation. Drug Deliv 23:238–47
  • Farhadian A, Dounighi NM, Avadi M. (2015). Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery. Hum Vaccin Immunother 11:2811–8
  • Felber AE, Dufresne MH, Leroux JC. (2012). pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv Drug Deliv Rev 64:979–92
  • Findlay M, Von Minckwitz G, Wardley A. (2008). Effective oral chemotherapy for breast cancer: pillars of strength. Ann Oncol 19:212–22
  • Fiorica C, Pitarresi G, Palumbo FS, et al. (2013). A new hyaluronic acid pH sensitive derivative obtained by ATRP for potential oral administration of proteins. Int J Pharm 457:150–7
  • Forbes DC, Peppas NA. (2014). Polymeric nanocarriers for siRNA delivery to murine macrophages. Macromol Biosci 14:1096–105
  • Fox CB, Kim J, Le LV, et al. (2015). Micro/nanofabricated platforms for oral drug delivery. J Control Release 219:431–44
  • Francis MF, Cristea M, Winnik FM. (2005). Exploiting the vitamin B12 pathway to enhance oral drug delivery via polymeric micelles. Biomacromolecules 6:2462–7
  • Gao X, Cao Y, Song X, et al. (2014). Biodegradable, pH-responsive carboxymethyl cellulose/poly(acrylic acid) hydrogels for oral insulin delivery. Macromol Biosci 14:565–75
  • Garinot M, Fievez V, Pourcelle V, et al. (2007). PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Release 120:195–204
  • George M, Abraham TE. (2006). Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review. J Control Release 114:1–14
  • Goldberg M, Gomez-Orellana I. (2003). Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov 2:289–95
  • Gu Y, Zhong Y, Meng F, et al. (2013). Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy. Biomacromolecules 14:2772–80
  • Guggi D, Krauland AH, Bernkop-Schnurch A. (2003). Systemic peptide delivery via the stomach: in vivo evaluation of an oral dosage form for salmon calcitonin. J Control Release 92:125–35
  • Gugulothu D, Kulkarni A, Patravale V, Dandekar P. (2014). pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model. J Pharm Sci 103:687–96
  • Guha A, Biswas N, Bhattacharjee K, et al. (2016). pH responsive cylindrical MSN for oral delivery of insulin- design, fabrication and evaluation. Drug Deliv 23:3552–61
  • Gullberg E, Keita AV, Salim SY, et al. (2006). Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer's patches. J Pharmacol Exp Ther 319:632–9
  • Hadi MA, Raghavendra Rao NG, Srinivasa Rao A. (2015). Pharmacokinetic parameters determination and in vitro-in vivo correlation of ileocolonic-targeted pH-responsive coated mini-tablets of naproxen. Sci Pharm 83:645–58
  • Hadi MA, Raghavendra Rao NG, Srinivasa Rao A. (2016). Formulation and evaluation of ileo-colonic targeted matrix-mini-tablets of naproxen for chronotherapeutic treatment of rheumatoid arthritis. Saudi Pharm J 24:64–73
  • Hadi MA, Rao NGR, Rao AS. (2014). Formulation and evaluation of pH-responsive mini-tablets for ileo-colonic targeted drug delivery. Trop J Pharm Res 13:1021–9
  • Han L, Zhao Y, Yin L, et al. (2012). Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular delivery. AAPS PharmSciTech 13:836–45
  • Han M, Fang QL, Zhan HW, et al. (2009). In vitro and in vivo evaluation of a novel capsule for colon-specific drug delivery. J Pharm Sci 98:2626–35
  • He P, Liu H, Tang Z, et al. (2013). Poly(ester amide) blend microspheres for oral insulin delivery. Int J Pharm 455:259–66
  • Higgins LM, Lambkin I, Donnelly G, et al. (2004). In vivo phage display to identify M cell-targeting ligands. Pharm Res 21:695–705
  • Hu Z, Shimokawa T, Ohno T, et al. (1999). Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F. J Drug Target 7:223–32
  • Huang Y, Leobandung W, Foss A, Peppas NA. (2000). Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J Control Release 65:63–71
  • Hurteaux R, Edwards-Levy F, Laurent-Maquin D, Levy MC. (2005). Coating alginate microspheres with a serum albumin-alginate membrane: application to the encapsulation of a peptide. Eur J Pharm Sci 24:187–97
  • Ichikawa H, Peppas NA. (2003). Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using caco-2 cell monolayers. J Biomed Mater Res A 67:609–17
  • Ignatious F, Sun L, Lee CP, Baldoni J. (2010). Electrospun nanofibers in oral drug delivery. Pharm Res 27:576–88
  • Jelvehgari M, Zakeri-Milani P, Siahi-Shadbad MR, et al. (2010). Development of pH-sensitive insulin nanoparticles using eudragit L100-55 and chitosan with different molecular weights. AAPS PharmSciTech 11:1237–42
  • Jia Z, Lin P, Xiang Y, et al. (2011). A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate. Eur J Pharm Biopharm 79:126–34
  • Jiang J, Xie J, MA B, et al. (2014). Mussel-inspired protein-mediated surface functionalization of electrospun nanofibers for pH-responsive drug delivery. Acta Biomater 10:1324–32
  • Kamei N, Morishita M, Chiba H, et al. (2009). Complexation hydrogels for intestinal delivery of interferon beta and calcitonin. J Control Release 134:98–102
  • Kankala RK, Kuthati Y, Sie HW, et al. (2015). Multi-laminated metal hydroxide nanocontainers for oral-specific delivery for bioavailability improvement and treatment of inflammatory paw edema in mice. J Colloid Interface Sci 458:217–28
  • Khalid MN, Agnely F, Yagoubi N, et al. (2002). Water state characterization, swelling behavior, thermal and mechanical properties of chitosan based networks. Eur J Pharm Sci 15:425–32
  • Khare AR, Peppas NA. (1995). Swelling/deswelling of anionic copolymer gels. Biomaterials 16:559–67
  • Kim B, Bowersock T, Griebel P, et al. (2002). Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres. J Control Release 85:191–202
  • Kim SH, Jang YS. (2014). Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp Mol Med 46:e85
  • Klier J, Scranton AB, Peppas N. (1990). Self-associating networks of poly (methacrylic acid-g-ethylene glycol). Macromolecules 23:4944–9
  • Knipe JM, Chen F, Peppas NA. (2015). Enzymatic biodegradation of hydrogels for protein delivery targeted to the small intestine. Biomacromolecules 16:962–72
  • Knipe JM, Strong LE, Peppas NA. (2016). Enzyme- and pH-responsive microencapsulated nanogels for oral delivery of siRNA to induce TNF-alpha knockdown in the intestine. Biomacromolecules 17:788–97
  • Koetting MC, Guido JF, Gupta M, et al. (2016). pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: effects of protein size, crosslinking density, and hydrogel degradation on protein delivery. J Control Release 221:18–25
  • Koetting MC, Peppas NA. (2014). pH-Responsive poly(itaconic acid-co-N-vinylpyrrolidone) hydrogels with reduced ionic strength loading solutions offer improved oral delivery potential for high isoelectric point-exhibiting therapeutic proteins. Int J Pharm 471:83–91
  • Kreuter J. (1996). Nanoparticles and microparticles for drug and vaccine delivery. J Anat 189 (Pt 3):503–5
  • Kulkarni AR, Soppimath KS, Aminabhavi TM, Rudzinski WE. (2001). In-vitro release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads. Eur J Pharm Biopharm 51:127–33
  • Kurkuri MD, Aminabhavi TM. (2004). Poly(vinyl alcohol) and poly(acrylic acid) sequential interpenetrating network pH-sensitive microspheres for the delivery of diclofenac sodium to the intestine. J Control Release 96:9–20
  • Lee CH, Lo LW, Mou CY, Yang CS. (2008a). Synthesis and characterization of positive-charge functionalized mesoporous silica nanoparticles for oral drug delivery of an anti-inflammatory drug. Adv Funct Mater 18:3283–92
  • Lee ES, Kim D, Youn YS, et al. (2008b). A virus-mimetic nanogel vehicle. Angew Chem Int Ed Engl 47:2418–21
  • Leroux JC, Cozens R, Roesel JL, et al. (1995). Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. J Pharm Sci 84:1387–91
  • Li MG, Lu WL, Wang JC, et al. (2007). Distribution, transition, adhesion and release of insulin loaded nanoparticles in the gut of rats. Int J Pharm 329:182–91
  • Li MG, Lu WL, Wang JC, et al. (2006). Preparation and characterization of insulin nanoparticles employing chitosan and poly(methylmethacrylate/methylmethacrylic acid) copolymer. J Nanosci Nanotechnol 6:2874–86
  • Li Z, Li H, Wang C, et al. (2016). Sodium dodecyl sulfate/β-cyclodextrin vesicles embedded in chitosan gel for insulin delivery with pH-selective release. Acta Pharm Sin B 6:344–51
  • Lin YH, Chang CH, Wu YS, et al. (2009). Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-helicobacter pylori therapy. Biomaterials 30:3332–42
  • Lin YH, Sonaje K, Lin KM, et al. (2008). Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J Control Release 132:141–9
  • Lo YL, Hsu CY, Lin HR. (2013). pH-and thermo-sensitive pluronic/poly(acrylic acid) in situ hydrogels for sustained release of an anticancer drug. J Drug Target 21:54–66
  • Lou H, Liu M, Wang L, et al. (2013). Development of a mini-tablet of co-grinded prednisone-neusilin complex for pediatric use. AAPS PharmSciTech 14:950–8
  • Lowman AM, Morishita M, Kajita M, et al. (1999). Oral delivery of insulin using pH-responsive complexation gels. J Pharm Sci 88:933–7
  • Makhlof A, Tozuka Y, Takeuchi H. (2009). pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. Eur J Pharm Biopharm 72:1–8
  • Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318
  • Momenzadeh S, Sadeghi A, Vatandoust N, Salehi R. (2015). Evaluation of in vivo transfection efficiency of eudragit coated nanoparticles of chitosan-DNA: a pH-sensitive system prepared for oral DNA delivery. Iran Red Crescent Med J 17:e16761
  • Mourya VK, Inamdar NN. (2008). Chitosan-modifications and applications: opportunities galore. React Funct Polym 68:1013–51
  • Mukhopadhyay P, Chakraborty S, Bhattacharya S, et al. (2015). pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery. Int J Biol Macromol 72:640–8
  • Mura S, Nicolas J, Couvreur P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12:991–1003
  • Mutalik S, Suthar NA, Managuli RS, et al. (2016). Development and performance evaluation of novel nanoparticles of a grafted copolymer loaded with curcumin. Int J Biol Macromol 86:709–20
  • Muzzarelli R, Baldassarre V, Conti F, et al. (1988). Biological activity of chitosan: ultrastructural study. Biomaterials 9:247–52
  • Ng KK, Lovell JF, Zheng G. (2011). Lipoprotein-inspired nanoparticles for cancer theranostics. Acc Chem Res 44:1105–13
  • Pan Y, Li YJ, Zhao HY, et al. (2002). Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 249:139–47
  • Patel VR, Amiji MM. (1996). Preparation and characterization of freeze-dried chitosan-poly(ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach. Pharm Res 13:588–93
  • Peppas NA. (2004). Devices based on intelligent biopolymers for oral protein delivery. Int J Pharm 277:11–7
  • Peppas NA, Bures P, Leobandung W, Ichikawa H. (2000). Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm 50:27–46
  • Peppas NA, Huang Y. (2004). Nanoscale technology of mucoadhesive interactions. Adv Drug Deliv Rev 56:1675–87
  • Peppas NA, Klier J. (1991). Controlled release by using poly (methacrylic acid-g-ethylene glycol) hydrogels. J Control Release 16:203–14
  • Perioli L, Pagano C. (2012). Inorganic matrices: an answer to low drug solubility problem. Expert Opin Drug Deliv 9:1559–72
  • Petrus AK, Allis DG, Smith RP, et al. (2009). Exploring the implications of vitamin B12 conjugation to insulin on insulin receptor binding. ChemMedChem 4:421–6
  • Pfeiffer P, Mortensen JP, Bjerregaard B, et al. (2006). Patient preference for oral or intravenous chemotherapy: a randomised cross-over trial comparing capecitabine and nordic fluorouracil/leucovorin in patients with colorectal cancer. Eur J Cancer 42:2738–43
  • Pitarresi G, Pierro P, Giammona G, et al. (2004). Drug release from alpha,beta-poly(N-2-hydroxyethyl)-DL-aspartamide-based microparticles. Biomaterials 25:4333–43
  • Prego C, Torres D, Fernandez-Megia E, et al. (2006). Chitosan-PEG nanocapsules as new carriers for oral peptide delivery: effect of chitosan pegylation degree. J Control Release 111:299–308
  • Qiu Y, Park K. (2001). Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 53:321–39
  • Qu W, Li Y, Hovgaard L, et al. (2012). A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1. Int J Nanomedicine 7:4983–94
  • Quellhorst E. (2002). Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration. J Am Soc Nephrol 13 Suppl 1:S92–6
  • Ranjha NM, Ayub G, Naseem S, Ansari MT. (2010). Preparation and characterization of hybrid pH-sensitive hydrogels of chitosan-co-acrylic acid for controlled release of verapamil. J Mater Sci Mater Med 21:2805–16
  • Rasmussen MR, Snabe T, Pedersen LH. (2003). Numerical modelling of insulin and amyloglucosidase release from swelling Ca-alginate beads. J Control Release 91:395–405
  • Rekha MR, Sharma CP. (2009). Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. J Control Release 135:144–51
  • Rekha MR, Sharma CP. (2015). Simultaneous effect of thiolation and carboxylation of chitosan particles towards mucoadhesive oral insulin delivery applications: an in vitro and in vivo evaluation. J Biomed Nanotechnol 11:165–76
  • Rencber S, Karavana SY, Yilmaz FF, et al. (2016). Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. Int J Nanomedicine 11:2641–53
  • Roine J, Kaasalainen M, Peurla M, et al. (2015). Controlled dissolution of griseofulvin solid dispersions from electrosprayed enteric polymer micromatrix particles: physicochemical characterization and in vitro evaluation. Mol Pharm 12:2254–64
  • Sandri G, Rossi S, Bonferoni MC, et al. (2005). Buccal penetration enhancement properties of N-trimethyl chitosan: influence of quaternization degree on absorption of a high molecular weight molecule. Int J Pharm 297:146–55
  • Schoener CA, Hutson HN, Peppas NA. (2013). pH-responsive hydrogels with dispersed hydrophobic nanoparticles for the oral delivery of chemotherapeutics. J Biomed Mater Res A 101:2229–36
  • Sharma P, Pathak K. (2013). Inulin-based tablet in capsule device for variable multipulse delivery of aceclofenac: optimization and in vivo roentgenography. AAPS PharmSciTech 14:736–47
  • Sharpe LA, Daily AM, Horava SD, Peppas NA. (2014). Therapeutic applications of hydrogels in oral drug delivery. Expert Opin Drug Deliv 11:901–15
  • Shi L, Yang L, Chen J, et al. (2004). Preparation and characterization of pH-sensitive hydrogel of chitosan/poly(acrylic acid) co-polymer. J Biomater Sci Polym Ed 15:465–74
  • Shrestha N, Shahbazi MA, Araujo F, et al. (2014). Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers. Biomaterials 35:7172–9
  • Shrestha N, Shahbazi MA, Araujo F, et al. (2015). Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: a controlled dual protein-drug delivery system. Biomaterials 68:9–20
  • Siew A, LE H, Thiovolet M, et al. (2012). Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles. Mol Pharm 9:14–28
  • Singh B, Maharjan S, Jiang T, et al. (2015). Attuning hydroxypropyl methylcellulose phthalate to oral delivery vehicle for effective and selective delivery of protein vaccine in ileum. Biomaterials 59:144–59
  • Sinha VR, Mittal BR, Bhutani KK, Kumria R. (2004). Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int J Pharm 269:101–8
  • Sonaje K, Chen YJ, Chen HL, et al. (2010a). Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials 31:3384–94
  • Sonaje K, Lin KJ, Wang JJ, et al. (2010b). Self-assembled pH-sensitive nanoparticles: a platform for oral delivery of protein drugs. Adv Funct Mater 20:3695–700
  • Sonaje K, Lin KJ, Wey SP, et al. (2010c). Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. Biomaterials 31:6849–58
  • Sonaje K, Lin YH, Juang JH, et al. (2009). In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30:2329–39
  • Sood A, Panchagnula R. (2001). Peroral route: an opportunity for protein and peptide drug delivery. Chem Rev 101:3275–303
  • Srivastava R, Kumar D, Pathak K. (2012). Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-targeted matrix tablet. Int J Pharm 427:153–62
  • Sun P, Li P, Li YM, et al. (2011). A pH-sensitive chitosan-tripolyphosphate hydrogel beads for controlled glipizide delivery. J Biomed Mater Res B Appl Biomater 97:175–83
  • Tahara Y, Mukai SA, Sawada S, et al. (2015). Nanocarrier-integrated microspheres: nanogel tectonic engineering for advanced drug-delivery systems. Adv Mater 27:5080–8
  • Tan JP, Goh CH, Tam KC. (2007). Comparative drug release studies of two cationic drugs from pH-responsive nanogels. Eur J Pharm Sci 32:340–8
  • Tan JP, Tam KC. (2007). Application of drug selective electrode in the drug release study of pH-responsive microgels. J Control Release 118:87–94
  • Thambi T, Yoon HY, Kim K, et al. (2011). Bioreducible block copolymers based on poly(ethylene glycol) and poly(gamma-benzyl L-glutamate) for intracellular delivery of camptothecin. Bioconjug Chem 22:1924–31
  • Torres-Lugo M, Garcia M, Record R, Peppas NA. (2002). Physicochemical behavior and cytotoxic effects of p(methacrylic acid-g-ethylene glycol) nanospheres for oral delivery of proteins. J Control Release 80:197–205
  • Verma A, Sharma S, Gupta PK, et al. (2016). Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: a mucoadhesive and pH responsive carrier for improved oral delivery of insulin. Acta Biomater 31:288–300
  • Wang XQ, Dai JD, Chen Z, et al. (2004). Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. J Control Release 97:421–9
  • Wang XQ, Dai JD, Zhang H, et al. (2008). Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats. J Nanosci Nanotechnol 8:2422–31
  • Wang XQ, Fan JM, Liu YO, et al. (2011). Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. Int J Pharm 419:339–46
  • Wang XQ, Zhang Q. (2012). pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. Eur J Pharm Biopharm 82:219–29
  • Xiao B, Merlin D. (2012). Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease. Expert Opin Drug Deliv 9:1393–407
  • Xie J, Liu G, Eden HS, et al. (2011). Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res 44:883–92
  • Xie J, Michael PL, Zhong S, et al. (2012). Mussel inspired protein-mediated surface modification to electrospun fibers and their potential biomedical applications. J Biomed Mater Res A 100:929–38
  • Xu W, Ling P, Zhang T. (2013). Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv 2013:340315
  • Xu Y, Du Y, Huang R, GAO L. (2003). Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier. Biomaterials 24:5015–22
  • Yamada K, Chen T, Kumar G, et al. (2000). Chitosan based water-resistant adhesive. Analogy to mussel glue. Biomacromolecules 1:252–8
  • Yang ZQ, Xu J, Pan P, Zhang XN. (2009). Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats. Pharmazie 64:26–31
  • Yin J, Xiang C, Song X. (2016). Nanoencapsulation of psoralidin via chitosan and Eudragit S100 for enhancement of oral bioavailability. Int J Pharm 510:203–9
  • Yoshida T, Lai TC, Kwon GS, Sako K. (2013). pH- and ion-sensitive polymers for drug delivery. Expert Opin Drug Deliv 10:1497–513
  • You R, Xiao C, Zhang L, Dong Y. (2015). Versatile particles from water-soluble chitosan and sodium alginate for loading toxic or bioactive substance. Int J Biol Macromol 79:498–503
  • Zhang L, Zeng Z, Hu C, et al. (2016). Controlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccines. Biomaterials 77:307–19
  • Zhang S, Bellinger AM, Glettig DL, et al. (2015). A pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices. Nat Mater 14:1065–71
  • Zheng Y, Yang W, Wang C, et al. (2007). Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: preparation, characterization and the use for 5-fluorouracil delivery. Eur J Pharm Biopharm 67:621–31
  • Zhou T, Xiao C, Fan J, et al. (2013). A nanogel of on-site tunable pH-response for efficient anticancer drug delivery. Acta Biomater 9:4546–57
  • Zhou X, Zhao Y, Chen S, et al. (2016). Self-assembly of pH-responsive microspheres for intestinal delivery of diverse lipophilic therapeutics. Biomacromolecules 17:2540–54